Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity

[1]  B. Vissel,et al.  The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain , 2020, Experimental Neurology.

[2]  J. Trempe,et al.  The Landscape of Parkin Variants Reveals Pathogenic Mechanisms and Therapeutic Targets in Parkinson's Disease. , 2019, Human molecular genetics.

[3]  E. Bézard,et al.  G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice , 2018, Neurobiology of Disease.

[4]  A. Tolkovsky,et al.  Neuronal Cell Death. , 2018, Physiological reviews.

[5]  M. Passafaro,et al.  The synaptic function of parkin , 2017, Brain : a journal of neurology.

[6]  E. Bézard,et al.  Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease , 2016, Neurobiology of Disease.

[7]  K. Lim,et al.  Parkin Regulation and Neurodegenerative Disorders , 2016, Front. Aging Neurosci..

[8]  A. Schleicher,et al.  Changes in the expression of neurotransmitter receptors in Parkin and DJ-1 knockout mice – A quantitative multireceptor study , 2015, Neuroscience.

[9]  Daniel F. A. R. Dourado,et al.  Structural and Functional Impact of Parkinson Disease‐Associated Mutations in the E3 Ubiquitin Ligase Parkin , 2015, Human mutation.

[10]  M. LaVoie,et al.  Pathologic and therapeutic implications for the cell biology of parkin , 2015, Molecular and Cellular Neuroscience.

[11]  M. Passafaro,et al.  Parkin regulates kainate receptors by interacting with the GluK2 subunit , 2014, Nature Communications.

[12]  B. Fakler,et al.  Mutant α-Synuclein Enhances Firing Frequencies in Dopamine Substantia Nigra Neurons by Oxidative Impairment of A-Type Potassium Channels , 2014, The Journal of Neuroscience.

[13]  C. Mulle,et al.  Contribution of aberrant GluK2-containing kainate receptors to chronic seizures in temporal lobe epilepsy. , 2014, Cell reports.

[14]  T. Dawson,et al.  Parkin and PINK1: much more than mitophagy , 2014, Trends in Neurosciences.

[15]  J. Lerma,et al.  Kainate Receptors in Health and Disease , 2013, Neuron.

[16]  J. Roeper.  Dissecting the diversity of midbrain dopamine neurons , 2013, Trends in Neurosciences.

[17]  D. Perrais,et al.  Cerebral Cortex doi:10.1093/cercor/bhs022 Cerebral Cortex Advance Access published February 17, 2012 Selective Block of Postsynaptic Kainate Receptors Reveals Their Function at Hippocampal Mossy Fiber Synapses , 2022 .

[18]  Kerstin Pingel,et al.  50 Years of Image Analysis , 2012 .

[19]  G. Paxinos,et al.  Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates , 2012 .

[20]  J. Bolam,et al.  Living on the edge with too many mouths to feed: Why dopamine neurons die , 2012, Movement disorders : official journal of the Movement Disorder Society.

[21]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[22]  C. A. Paladini,et al.  Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms , 2011, Neuroscience.

[23]  C. Mulle,et al.  Kainate receptors coming of age: milestones of two decades of research , 2011, Trends in Neurosciences.

[24]  D. Jane,et al.  Mapping the Ligand Binding Sites of Kainate Receptors: Molecular Determinants of Subunit-Selective Binding of the Antagonist [3H]UBP310 , 2010, Molecular Pharmacology.

[25]  Ted M. Dawson,et al.  Genetic Animal Models of Parkinson's Disease , 2010, Neuron.

[26]  M. Chesselet,et al.  Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant α-Synuclein , 2009, The Journal of Neuroscience.

[27]  D. Jane,et al.  Antagonism of recombinant and native GluK3-containing kainate receptors , 2009, Neuropharmacology.

[28]  Ruifeng Lu,et al.  Drosophila Overexpressing Parkin R275W Mutant Exhibits Dopaminergic Neuron Degeneration and Mitochondrial Abnormalities , 2007, The Journal of Neuroscience.

[29]  Penny A. MacDonald,et al.  Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels. , 2007, Molecular biology of the cell.

[30]  G. Collingridge,et al.  Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLUK5 kainate receptor antagonists. , 2007, Journal of medicinal chemistry.

[31]  George R Jackson,et al.  A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine , 2007, The Journal of Neuroscience.

[32]  K. Davis,et al.  Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia. , 2004, Brain research. Molecular brain research.

[33]  F. Moreau,et al.  Parkin and CASK/LIN-2 Associate via a PDZ-mediated Interaction and Are Co-localized in Lipid Rafts and Postsynaptic Densities in Brain* , 2002, The Journal of Biological Chemistry.

[34]  S. Minoshima,et al.  Parkin is associated with cellular vesicles , 2001, Journal of neurochemistry.

[35]  Gundersen,et al.  Global spatial sampling with isotropic virtual planes: estimators of length density and total length in thick, arbitrarily orientated sections , 1998, Journal of microscopy.

[36]  A. Brookes,et al.  Point Mutations (Thr240Arg and Ala311Stop) in theParkinGene , 1998 .

[37]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[38]  S. T. Kitai,et al.  Electrophysiological and immunocytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat , 1997, Neuroscience.

[39]  Paul J. Harrison,et al.  Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia , 1997, Brain Research.

[40]  C. Mulle,et al.  Subcellular localization and trafficking of kainate receptors. , 2005, Trends in pharmacological sciences.